Bio
A graduate of the NYU School of Medicine, Dr. Kopell completed his residency at NYU Medical Center. He completed undergone fellowship training in Functional and Restorative Neurosurgery at the Cleveland Clinic Foundation and the University of Zurich. For the past eight years, he founded and led the Restorative Neuroscience Program at the Medical College of Wisconsin (Milwaukee, WI) where his team performed over 400 DBS cases for movement disorders.
Dr. Kopell has participated and been principal investigator in several clinical trials of emerging Neuromodulation technologies targeting such disorders as Parkinson's disease, tremor, tinnitus, and major depression. Dr. Kopell has pioneered the use of intraoperative imaging during DBS cases to supplement the microelectrode recording typically done to make a procedure that is safer and quicker for patients.
Deep Brain Stimulation (DBS) is widely recognized as the gold-standard treatment for patients with disabling motor symptoms from idiopathic Parkinson's disease, Essential Tremor, and Dystonia that have become refractory to medical therapy. This neurosurgical procedure is available within a fully integrated multidisciplinary program through the Mount Sinai Hospital.
Dr. Kopell has participated and been principal investigator in several clinical trials of emerging Neuromodulation technologies targeting such disorders as Parkinson's disease, tremor, tinnitus, and major depression. Dr. Kopell has pioneered the use of intraoperative imaging during DBS cases to supplement the microelectrode recording typically done to make a procedure that is safer and quicker for patients.
Deep Brain Stimulation (DBS) is widely recognized as the gold-standard treatment for patients with disabling motor symptoms from idiopathic Parkinson's disease, Essential Tremor, and Dystonia that have become refractory to medical therapy. This neurosurgical procedure is available within a fully integrated multidisciplinary program through the Mount Sinai Hospital.
